In a press release from November 2023, the company announced that they were bringing lawsuits against two compounding pharmacies for selling adulterated and misbranded compounded drugs claiming to contain semaglutide. In a statement to Healthline, a Novo Nordisk representative said: To date, Novo Nordisk has filed a total of 12 legal actions against medical spas, weight loss or medical clinics, and compounding pharmacies to cease and desist from false advertising, trademark infringement and unlawful sales of non-FDA approved compounded products claiming to contain semaglutide
While compounded tirzepatide reports to contains the same active ingredient as Mounjaro , it is not FDA approved
While the first hypothesis is plausible for MEPP, it is unlikely for AEPP, which exhibited very weak inhibitory activity against hydroxyl radical formation
Resistance bands, free weights, and machines all offer effective options
Why does it work
Customers should verify the final payment amount and billing schedule before completing checkout